nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—CYP2B6—Dexamethasone—ankylosing spondylitis	0.146	0.234	CbGbCtD
Thiotepa—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.119	0.19	CbGbCtD
Thiotepa—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0901	0.144	CbGbCtD
Thiotepa—CYP3A4—Betamethasone—ankylosing spondylitis	0.0773	0.124	CbGbCtD
Thiotepa—CYP3A4—Prednisolone—ankylosing spondylitis	0.0763	0.122	CbGbCtD
Thiotepa—CYP3A4—Prednisone—ankylosing spondylitis	0.072	0.115	CbGbCtD
Thiotepa—CYP3A4—Dexamethasone—ankylosing spondylitis	0.045	0.0718	CbGbCtD
Thiotepa—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000652	0.00174	CcSEcCtD
Thiotepa—Erythema—Methylprednisolone—ankylosing spondylitis	0.000652	0.00174	CcSEcCtD
Thiotepa—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000637	0.0017	CcSEcCtD
Thiotepa—Eye disorder—Betamethasone—ankylosing spondylitis	0.000637	0.0017	CcSEcCtD
Thiotepa—Back pain—Triamcinolone—ankylosing spondylitis	0.000632	0.00169	CcSEcCtD
Thiotepa—Angiopathy—Betamethasone—ankylosing spondylitis	0.000618	0.00165	CcSEcCtD
Thiotepa—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000618	0.00165	CcSEcCtD
Thiotepa—Convulsion—Prednisolone—ankylosing spondylitis	0.000616	0.00165	CcSEcCtD
Thiotepa—Hypertension—Prednisolone—ankylosing spondylitis	0.000613	0.00164	CcSEcCtD
Thiotepa—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000608	0.00163	CcSEcCtD
Thiotepa—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000608	0.00163	CcSEcCtD
Thiotepa—Alopecia—Dexamethasone—ankylosing spondylitis	0.000602	0.00161	CcSEcCtD
Thiotepa—Alopecia—Betamethasone—ankylosing spondylitis	0.000602	0.00161	CcSEcCtD
Thiotepa—Haemoglobin—Prednisone—ankylosing spondylitis	0.000596	0.00159	CcSEcCtD
Thiotepa—Haemorrhage—Prednisone—ankylosing spondylitis	0.000593	0.00158	CcSEcCtD
Thiotepa—Erythema—Dexamethasone—ankylosing spondylitis	0.000593	0.00158	CcSEcCtD
Thiotepa—Erythema—Betamethasone—ankylosing spondylitis	0.000593	0.00158	CcSEcCtD
Thiotepa—Hallucination—Prednisone—ankylosing spondylitis	0.00059	0.00158	CcSEcCtD
Thiotepa—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000588	0.00157	CcSEcCtD
Thiotepa—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000583	0.00156	CcSEcCtD
Thiotepa—Dysuria—Methotrexate—ankylosing spondylitis	0.000579	0.00155	CcSEcCtD
Thiotepa—Cough—Triamcinolone—ankylosing spondylitis	0.00057	0.00152	CcSEcCtD
Thiotepa—Convulsion—Triamcinolone—ankylosing spondylitis	0.000566	0.00151	CcSEcCtD
Thiotepa—Tachycardia—Prednisolone—ankylosing spondylitis	0.000566	0.00151	CcSEcCtD
Thiotepa—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000565	0.00151	CcSEcCtD
Thiotepa—Hypertension—Triamcinolone—ankylosing spondylitis	0.000564	0.00151	CcSEcCtD
Thiotepa—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000563	0.0015	CcSEcCtD
Thiotepa—Myalgia—Triamcinolone—ankylosing spondylitis	0.000556	0.00149	CcSEcCtD
Thiotepa—Pneumonia—Methotrexate—ankylosing spondylitis	0.000555	0.00148	CcSEcCtD
Thiotepa—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000555	0.00148	CcSEcCtD
Thiotepa—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000555	0.00148	CcSEcCtD
Thiotepa—Eye disorder—Prednisone—ankylosing spondylitis	0.000554	0.00148	CcSEcCtD
Thiotepa—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000553	0.00148	CcSEcCtD
Thiotepa—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000552	0.00148	CcSEcCtD
Thiotepa—Infestation—Methotrexate—ankylosing spondylitis	0.000552	0.00148	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000551	0.00147	CcSEcCtD
Thiotepa—Renal failure—Methotrexate—ankylosing spondylitis	0.000543	0.00145	CcSEcCtD
Thiotepa—Stomatitis—Methotrexate—ankylosing spondylitis	0.000538	0.00144	CcSEcCtD
Thiotepa—Angiopathy—Prednisone—ankylosing spondylitis	0.000538	0.00144	CcSEcCtD
Thiotepa—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000537	0.00143	CcSEcCtD
Thiotepa—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000537	0.00143	CcSEcCtD
Thiotepa—Immune system disorder—Prednisone—ankylosing spondylitis	0.000536	0.00143	CcSEcCtD
Thiotepa—Arrhythmia—Prednisone—ankylosing spondylitis	0.00053	0.00142	CcSEcCtD
Thiotepa—Infection—Triamcinolone—ankylosing spondylitis	0.00053	0.00142	CcSEcCtD
Thiotepa—Infection—Methylprednisolone—ankylosing spondylitis	0.000529	0.00141	CcSEcCtD
Thiotepa—Haematuria—Methotrexate—ankylosing spondylitis	0.000527	0.00141	CcSEcCtD
Thiotepa—Alopecia—Prednisone—ankylosing spondylitis	0.000524	0.0014	CcSEcCtD
Thiotepa—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000522	0.0014	CcSEcCtD
Thiotepa—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000522	0.00139	CcSEcCtD
Thiotepa—Epistaxis—Methotrexate—ankylosing spondylitis	0.000521	0.00139	CcSEcCtD
Thiotepa—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000521	0.00139	CcSEcCtD
Thiotepa—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00052	0.00139	CcSEcCtD
Thiotepa—Mental disorder—Prednisone—ankylosing spondylitis	0.00052	0.00139	CcSEcCtD
Thiotepa—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000519	0.00139	CcSEcCtD
Thiotepa—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000517	0.00138	CcSEcCtD
Thiotepa—Erythema—Prednisone—ankylosing spondylitis	0.000516	0.00138	CcSEcCtD
Thiotepa—Malnutrition—Prednisone—ankylosing spondylitis	0.000516	0.00138	CcSEcCtD
Thiotepa—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000515	0.00138	CcSEcCtD
Thiotepa—Convulsion—Dexamethasone—ankylosing spondylitis	0.000514	0.00137	CcSEcCtD
Thiotepa—Convulsion—Betamethasone—ankylosing spondylitis	0.000514	0.00137	CcSEcCtD
Thiotepa—Hypertension—Dexamethasone—ankylosing spondylitis	0.000512	0.00137	CcSEcCtD
Thiotepa—Hypertension—Betamethasone—ankylosing spondylitis	0.000512	0.00137	CcSEcCtD
Thiotepa—Myalgia—Betamethasone—ankylosing spondylitis	0.000505	0.00135	CcSEcCtD
Thiotepa—Myalgia—Dexamethasone—ankylosing spondylitis	0.000505	0.00135	CcSEcCtD
Thiotepa—Anxiety—Dexamethasone—ankylosing spondylitis	0.000503	0.00134	CcSEcCtD
Thiotepa—Anxiety—Betamethasone—ankylosing spondylitis	0.000503	0.00134	CcSEcCtD
Thiotepa—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000498	0.00133	CcSEcCtD
Thiotepa—Pain—Prednisolone—ankylosing spondylitis	0.000496	0.00133	CcSEcCtD
Thiotepa—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000496	0.00132	CcSEcCtD
Thiotepa—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00049	0.00131	CcSEcCtD
Thiotepa—Vision blurred—Prednisone—ankylosing spondylitis	0.000487	0.0013	CcSEcCtD
Thiotepa—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000486	0.0013	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000486	0.0013	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000485	0.0013	CcSEcCtD
Thiotepa—Infection—Betamethasone—ankylosing spondylitis	0.000481	0.00128	CcSEcCtD
Thiotepa—Infection—Dexamethasone—ankylosing spondylitis	0.000481	0.00128	CcSEcCtD
Thiotepa—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000479	0.00128	CcSEcCtD
Thiotepa—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000478	0.00128	CcSEcCtD
Thiotepa—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000478	0.00128	CcSEcCtD
Thiotepa—Anaemia—Prednisone—ankylosing spondylitis	0.000477	0.00128	CcSEcCtD
Thiotepa—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000475	0.00127	CcSEcCtD
Thiotepa—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000475	0.00127	CcSEcCtD
Thiotepa—Agitation—Prednisone—ankylosing spondylitis	0.000475	0.00127	CcSEcCtD
Thiotepa—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000474	0.00127	CcSEcCtD
Thiotepa—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000474	0.00127	CcSEcCtD
Thiotepa—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000472	0.00126	CcSEcCtD
Thiotepa—Tachycardia—Betamethasone—ankylosing spondylitis	0.000472	0.00126	CcSEcCtD
Thiotepa—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000469	0.00125	CcSEcCtD
Thiotepa—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000468	0.00125	CcSEcCtD
Thiotepa—Eye disorder—Methotrexate—ankylosing spondylitis	0.000463	0.00124	CcSEcCtD
Thiotepa—Tinnitus—Methotrexate—ankylosing spondylitis	0.000462	0.00123	CcSEcCtD
Thiotepa—Anorexia—Betamethasone—ankylosing spondylitis	0.000461	0.00123	CcSEcCtD
Thiotepa—Anorexia—Dexamethasone—ankylosing spondylitis	0.000461	0.00123	CcSEcCtD
Thiotepa—Urticaria—Prednisolone—ankylosing spondylitis	0.000461	0.00123	CcSEcCtD
Thiotepa—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00046	0.00123	CcSEcCtD
Thiotepa—Fatigue—Triamcinolone—ankylosing spondylitis	0.00046	0.00123	CcSEcCtD
Thiotepa—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000459	0.00123	CcSEcCtD
Thiotepa—Pain—Triamcinolone—ankylosing spondylitis	0.000456	0.00122	CcSEcCtD
Thiotepa—Angiopathy—Methotrexate—ankylosing spondylitis	0.00045	0.0012	CcSEcCtD
Thiotepa—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000448	0.0012	CcSEcCtD
Thiotepa—Convulsion—Prednisone—ankylosing spondylitis	0.000447	0.0012	CcSEcCtD
Thiotepa—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000447	0.00119	CcSEcCtD
Thiotepa—Hypertension—Prednisone—ankylosing spondylitis	0.000446	0.00119	CcSEcCtD
Thiotepa—Chills—Methotrexate—ankylosing spondylitis	0.000445	0.00119	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000441	0.00118	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000441	0.00118	CcSEcCtD
Thiotepa—Myalgia—Prednisone—ankylosing spondylitis	0.00044	0.00117	CcSEcCtD
Thiotepa—Arthralgia—Prednisone—ankylosing spondylitis	0.00044	0.00117	CcSEcCtD
Thiotepa—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000439	0.00117	CcSEcCtD
Thiotepa—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000438	0.00117	CcSEcCtD
Thiotepa—Anxiety—Prednisone—ankylosing spondylitis	0.000438	0.00117	CcSEcCtD
Thiotepa—Alopecia—Methotrexate—ankylosing spondylitis	0.000438	0.00117	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000437	0.00117	CcSEcCtD
Thiotepa—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000435	0.00116	CcSEcCtD
Thiotepa—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000435	0.00116	CcSEcCtD
Thiotepa—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000435	0.00116	CcSEcCtD
Thiotepa—Mental disorder—Methotrexate—ankylosing spondylitis	0.000434	0.00116	CcSEcCtD
Thiotepa—Malnutrition—Methotrexate—ankylosing spondylitis	0.000432	0.00115	CcSEcCtD
Thiotepa—Erythema—Methotrexate—ankylosing spondylitis	0.000432	0.00115	CcSEcCtD
Thiotepa—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000427	0.00114	CcSEcCtD
Thiotepa—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000426	0.00114	CcSEcCtD
Thiotepa—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000426	0.00114	CcSEcCtD
Thiotepa—Urticaria—Triamcinolone—ankylosing spondylitis	0.000424	0.00113	CcSEcCtD
Thiotepa—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000423	0.00113	CcSEcCtD
Thiotepa—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000422	0.00113	CcSEcCtD
Thiotepa—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000421	0.00112	CcSEcCtD
Thiotepa—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000421	0.00112	CcSEcCtD
Thiotepa—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000421	0.00112	CcSEcCtD
Thiotepa—Infection—Prednisone—ankylosing spondylitis	0.000419	0.00112	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000418	0.00112	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000418	0.00112	CcSEcCtD
Thiotepa—Back pain—Methotrexate—ankylosing spondylitis	0.000417	0.00112	CcSEcCtD
Thiotepa—Fatigue—Dexamethasone—ankylosing spondylitis	0.000417	0.00111	CcSEcCtD
Thiotepa—Fatigue—Betamethasone—ankylosing spondylitis	0.000417	0.00111	CcSEcCtD
Thiotepa—Pain—Betamethasone—ankylosing spondylitis	0.000414	0.00111	CcSEcCtD
Thiotepa—Pain—Dexamethasone—ankylosing spondylitis	0.000414	0.00111	CcSEcCtD
Thiotepa—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000413	0.0011	CcSEcCtD
Thiotepa—Tachycardia—Prednisone—ankylosing spondylitis	0.000411	0.0011	CcSEcCtD
Thiotepa—Skin disorder—Prednisone—ankylosing spondylitis	0.000409	0.00109	CcSEcCtD
Thiotepa—Vision blurred—Methotrexate—ankylosing spondylitis	0.000407	0.00109	CcSEcCtD
Thiotepa—Anorexia—Prednisone—ankylosing spondylitis	0.000402	0.00107	CcSEcCtD
Thiotepa—Anaemia—Methotrexate—ankylosing spondylitis	0.000399	0.00107	CcSEcCtD
Thiotepa—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000399	0.00107	CcSEcCtD
Thiotepa—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000399	0.00107	CcSEcCtD
Thiotepa—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000396	0.00106	CcSEcCtD
Thiotepa—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000396	0.00106	CcSEcCtD
Thiotepa—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000393	0.00105	CcSEcCtD
Thiotepa—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000392	0.00105	CcSEcCtD
Thiotepa—Leukopenia—Methotrexate—ankylosing spondylitis	0.000386	0.00103	CcSEcCtD
Thiotepa—Urticaria—Dexamethasone—ankylosing spondylitis	0.000384	0.00103	CcSEcCtD
Thiotepa—Urticaria—Betamethasone—ankylosing spondylitis	0.000384	0.00103	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000384	0.00103	CcSEcCtD
Thiotepa—Dizziness—Prednisolone—ankylosing spondylitis	0.000383	0.00102	CcSEcCtD
Thiotepa—Asthenia—Triamcinolone—ankylosing spondylitis	0.000383	0.00102	CcSEcCtD
Thiotepa—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000383	0.00102	CcSEcCtD
Thiotepa—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000383	0.00102	CcSEcCtD
Thiotepa—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000383	0.00102	CcSEcCtD
Thiotepa—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000383	0.00102	CcSEcCtD
Thiotepa—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000382	0.00102	CcSEcCtD
Thiotepa—Paraesthesia—Prednisone—ankylosing spondylitis	0.000378	0.00101	CcSEcCtD
Thiotepa—Pruritus—Triamcinolone—ankylosing spondylitis	0.000377	0.00101	CcSEcCtD
Thiotepa—Cough—Methotrexate—ankylosing spondylitis	0.000377	0.00101	CcSEcCtD
Thiotepa—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000376	0.00101	CcSEcCtD
Thiotepa—Convulsion—Methotrexate—ankylosing spondylitis	0.000374	0.000999	CcSEcCtD
Thiotepa—Dyspepsia—Prednisone—ankylosing spondylitis	0.000371	0.000991	CcSEcCtD
Thiotepa—Arthralgia—Methotrexate—ankylosing spondylitis	0.000367	0.000982	CcSEcCtD
Thiotepa—Myalgia—Methotrexate—ankylosing spondylitis	0.000367	0.000982	CcSEcCtD
Thiotepa—Decreased appetite—Prednisone—ankylosing spondylitis	0.000366	0.000979	CcSEcCtD
Thiotepa—Rash—Prednisolone—ankylosing spondylitis	0.000366	0.000977	CcSEcCtD
Thiotepa—Dermatitis—Prednisolone—ankylosing spondylitis	0.000365	0.000976	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000365	0.000975	CcSEcCtD
Thiotepa—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000364	0.000973	CcSEcCtD
Thiotepa—Fatigue—Prednisone—ankylosing spondylitis	0.000363	0.000971	CcSEcCtD
Thiotepa—Headache—Prednisolone—ankylosing spondylitis	0.000363	0.000971	CcSEcCtD
Thiotepa—Constipation—Prednisone—ankylosing spondylitis	0.00036	0.000963	CcSEcCtD
Thiotepa—Confusional state—Methotrexate—ankylosing spondylitis	0.000355	0.000949	CcSEcCtD
Thiotepa—Dizziness—Triamcinolone—ankylosing spondylitis	0.000353	0.000942	CcSEcCtD
Thiotepa—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000352	0.00094	CcSEcCtD
Thiotepa—Infection—Methotrexate—ankylosing spondylitis	0.00035	0.000935	CcSEcCtD
Thiotepa—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000347	0.000928	CcSEcCtD
Thiotepa—Asthenia—Betamethasone—ankylosing spondylitis	0.000347	0.000928	CcSEcCtD
Thiotepa—Asthenia—Dexamethasone—ankylosing spondylitis	0.000347	0.000928	CcSEcCtD
Thiotepa—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000345	0.000923	CcSEcCtD
Thiotepa—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000345	0.000921	CcSEcCtD
Thiotepa—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000345	0.000921	CcSEcCtD
Thiotepa—Nausea—Prednisolone—ankylosing spondylitis	0.000344	0.00092	CcSEcCtD
Thiotepa—Pruritus—Dexamethasone—ankylosing spondylitis	0.000342	0.000915	CcSEcCtD
Thiotepa—Pruritus—Betamethasone—ankylosing spondylitis	0.000342	0.000915	CcSEcCtD
Thiotepa—Skin disorder—Methotrexate—ankylosing spondylitis	0.000342	0.000914	CcSEcCtD
Thiotepa—Vomiting—Triamcinolone—ankylosing spondylitis	0.000339	0.000906	CcSEcCtD
Thiotepa—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000338	0.000904	CcSEcCtD
Thiotepa—Rash—Triamcinolone—ankylosing spondylitis	0.000336	0.000898	CcSEcCtD
Thiotepa—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000336	0.000898	CcSEcCtD
Thiotepa—Anorexia—Methotrexate—ankylosing spondylitis	0.000336	0.000897	CcSEcCtD
Thiotepa—Rash—Methylprednisolone—ankylosing spondylitis	0.000336	0.000896	CcSEcCtD
Thiotepa—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000335	0.000896	CcSEcCtD
Thiotepa—Urticaria—Prednisone—ankylosing spondylitis	0.000335	0.000895	CcSEcCtD
Thiotepa—Headache—Triamcinolone—ankylosing spondylitis	0.000334	0.000893	CcSEcCtD
Thiotepa—Headache—Methylprednisolone—ankylosing spondylitis	0.000333	0.000891	CcSEcCtD
Thiotepa—Body temperature increased—Prednisone—ankylosing spondylitis	0.000333	0.00089	CcSEcCtD
Thiotepa—Abdominal pain—Prednisone—ankylosing spondylitis	0.000333	0.00089	CcSEcCtD
Thiotepa—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000331	0.000885	CcSEcCtD
Thiotepa—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000331	0.000885	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000321	0.000857	CcSEcCtD
Thiotepa—Dizziness—Dexamethasone—ankylosing spondylitis	0.00032	0.000855	CcSEcCtD
Thiotepa—Dizziness—Betamethasone—ankylosing spondylitis	0.00032	0.000855	CcSEcCtD
Thiotepa—Nausea—Triamcinolone—ankylosing spondylitis	0.000317	0.000846	CcSEcCtD
Thiotepa—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000316	0.000845	CcSEcCtD
Thiotepa—Nausea—Methylprednisolone—ankylosing spondylitis	0.000316	0.000845	CcSEcCtD
Thiotepa—Somnolence—Methotrexate—ankylosing spondylitis	0.000313	0.000837	CcSEcCtD
Thiotepa—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00031	0.00083	CcSEcCtD
Thiotepa—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00031	0.000828	CcSEcCtD
Thiotepa—Vomiting—Betamethasone—ankylosing spondylitis	0.000308	0.000822	CcSEcCtD
Thiotepa—Vomiting—Dexamethasone—ankylosing spondylitis	0.000308	0.000822	CcSEcCtD
Thiotepa—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000306	0.000818	CcSEcCtD
Thiotepa—Rash—Betamethasone—ankylosing spondylitis	0.000305	0.000815	CcSEcCtD
Thiotepa—Rash—Dexamethasone—ankylosing spondylitis	0.000305	0.000815	CcSEcCtD
Thiotepa—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000305	0.000814	CcSEcCtD
Thiotepa—Dermatitis—Betamethasone—ankylosing spondylitis	0.000305	0.000814	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000304	0.000812	CcSEcCtD
Thiotepa—Fatigue—Methotrexate—ankylosing spondylitis	0.000304	0.000811	CcSEcCtD
Thiotepa—Headache—Betamethasone—ankylosing spondylitis	0.000303	0.00081	CcSEcCtD
Thiotepa—Headache—Dexamethasone—ankylosing spondylitis	0.000303	0.00081	CcSEcCtD
Thiotepa—Asthenia—Prednisone—ankylosing spondylitis	0.000302	0.000808	CcSEcCtD
Thiotepa—Pain—Methotrexate—ankylosing spondylitis	0.000301	0.000805	CcSEcCtD
Thiotepa—Pruritus—Prednisone—ankylosing spondylitis	0.000298	0.000797	CcSEcCtD
Thiotepa—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00029	0.000775	CcSEcCtD
Thiotepa—Diarrhoea—Prednisone—ankylosing spondylitis	0.000288	0.00077	CcSEcCtD
Thiotepa—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000288	0.000769	CcSEcCtD
Thiotepa—Nausea—Betamethasone—ankylosing spondylitis	0.000287	0.000768	CcSEcCtD
Thiotepa—Nausea—Dexamethasone—ankylosing spondylitis	0.000287	0.000768	CcSEcCtD
Thiotepa—Urticaria—Methotrexate—ankylosing spondylitis	0.00028	0.000748	CcSEcCtD
Thiotepa—Dizziness—Prednisone—ankylosing spondylitis	0.000279	0.000745	CcSEcCtD
Thiotepa—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000278	0.000744	CcSEcCtD
Thiotepa—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000278	0.000744	CcSEcCtD
Thiotepa—Vomiting—Prednisone—ankylosing spondylitis	0.000268	0.000716	CcSEcCtD
Thiotepa—Rash—Prednisone—ankylosing spondylitis	0.000266	0.00071	CcSEcCtD
Thiotepa—Dermatitis—Prednisone—ankylosing spondylitis	0.000265	0.000709	CcSEcCtD
Thiotepa—Headache—Prednisone—ankylosing spondylitis	0.000264	0.000705	CcSEcCtD
Thiotepa—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000259	0.000693	CcSEcCtD
Thiotepa—Asthenia—Methotrexate—ankylosing spondylitis	0.000253	0.000675	CcSEcCtD
Thiotepa—Nausea—Prednisone—ankylosing spondylitis	0.00025	0.000669	CcSEcCtD
Thiotepa—Pruritus—Methotrexate—ankylosing spondylitis	0.000249	0.000666	CcSEcCtD
Thiotepa—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000241	0.000644	CcSEcCtD
Thiotepa—Dizziness—Methotrexate—ankylosing spondylitis	0.000233	0.000622	CcSEcCtD
Thiotepa—Vomiting—Methotrexate—ankylosing spondylitis	0.000224	0.000598	CcSEcCtD
Thiotepa—Rash—Methotrexate—ankylosing spondylitis	0.000222	0.000593	CcSEcCtD
Thiotepa—Dermatitis—Methotrexate—ankylosing spondylitis	0.000222	0.000593	CcSEcCtD
Thiotepa—Headache—Methotrexate—ankylosing spondylitis	0.000221	0.00059	CcSEcCtD
Thiotepa—Nausea—Methotrexate—ankylosing spondylitis	0.000209	0.000559	CcSEcCtD
